Citation: Feize Li, Yuanyou Yang, Jiali Liao, Ning Liu. Recent progress of astatine-211 in endoradiotherapy: Great advances from fundamental properties to targeted radiopharmaceuticals[J]. Chinese Chemical Letters, ;2022, 33(7): 3325-3338. doi: 10.1016/j.cclet.2022.03.025 shu

Recent progress of astatine-211 in endoradiotherapy: Great advances from fundamental properties to targeted radiopharmaceuticals

Key Laboratory of Radiation Physics and Technology of the Ministry of Education, Institute of Nuclear Science and Technology, Sichuan University, Chengdu 610064, China

nliu720@scu.edu.cn

Received Date: 26 December 2021
Revised Date: 1 March 2022
Accepted Date: 6 March 2022
Available Online: 9 March 2022

Figures(3)

Astatine-211 (²¹¹At, t_1/2 = 7.21 h) emitting two α particles with energies of 5.87 and 7.45 MeV, can lead to a high linear energy transfer (LET = 98.84 keV/µm) and short tissue range (50~90 µm). Since the 1950s, ²¹¹At had stepped into endoradiotherapy and has always been regarded as one of the most promising α-emitters for targeted-alpha therapy (TAT) in various malignancies. In the past two decades, ²¹¹At related radiopharmaceuticals have achieved great progress in the studies of basic physicochemical properties of astatine, ²¹¹At labeling strategies, preclinical and clinical studies, producing profound effects in nuclear medicine. This work will give a panorama of ²¹¹At-related researches in the recent 20 years, which will cover both the fundamental insights of ²¹¹At radiochemistry and applied labeling compounds. It can provide some important hints for the studies of TAT and other radiopharmaceuticals applied in tumor radiotherapy.
- Radionuclides,
- Astatine-211,
- Target-alpha therapy,
- Radiopharmaceuticals
1. [1]
  K. Claesson, K. Magnander, H. Kahu, et al., Int. J. Radiat. Biol. 87 (2011) 372–384. doi: 10.3109/09553002.2011.538127
2. [2]
  A.K. Claesson, B. Stenerlow, L. Jacobsson, et al., Radiat. Res. 167 (2007) 312–318. doi: 10.1667/RR0668.1
3. [3]
  J. Tranel, F.Y. Feng, S. St James, et al., Phys. Med. Biol. 66 (2021) 035016. doi: 10.1088/1361-6560/abd3ef
4. [4]
  S. Lindegren, P. Albertsson, T. Back, et al., Cancer Biother. Radiopharm. 35 (2020) 425–436. doi: 10.1089/cbr.2019.3055
5. [5]
  M.G. Ferrier, V. Radchenko, J. Med. Imaging Radia. Sci. 50 (2019) S58–S65. doi: 10.1016/j.jmir.2019.06.051
6. [6]
  R. Eychenne, M. Cherel, F. Haddad, et al., Pharmaceutics 13 (2021) 906. doi: 10.3390/pharmaceutics13060906
7. [7]
  M.R. Zalutsky, G. Vaidyanathan, Curr. Pharm. Des. 6 (2000) 1433–1455. doi: 10.2174/1381612003399275
8. [8]
  F. Guerard, J.F. Gestin, M.W. Brechbiel, Cancer Biother. Radiopharm. 28 (2013) 1–20. doi: 10.1089/cbr.2012.1292
9. [9]
  S. Palm, J.L. Humm, R. Rundqvist, et al., Med. Phys. 31 (2004) 218–225. doi: 10.1118/1.1640951
10. [10]
  T. Watabe, K. Kaneda-Nakashima, Y. Liu, et al., J. Nucl. Med. 60 (2019) 1301–1307. doi: 10.2967/jnumed.118.222638
11. [11]
  T.G. Turkington, M.R. Zalutsky, R.J. Jaszczak, et al. Phys. Med. Biol. 38 (1993) 1121–1130. doi: 10.1088/0031-9155/38/8/010
12. [12]
  K. Nakanishi, S. Yamamoto, T. Watabe, et al., Med. Phys. 47 (2020) 5739–5748. doi: 10.1002/mp.14455
13. [13]
  Y. Nagao, M. Yamaguchi, S. Watanabe, et al., Appl. Radiat. Isot. 139 (2018) 238–243. doi: 10.1016/j.apradiso.2018.05.022
14. [14]
  J.G. Hamilton, C.W. Asling, W.M. Garrison, et al., Proc. Soc. Exp. Biol. Med. 73 (1950) 51–53. doi: 10.3181/00379727-73-17572
15. [15]
  B.J.B. Nelson, J.D. Andersson, F. Wuest, Pharmaceutics 13 (2021) 49. doi: 10.1007/978-3-030-81277-5_4
16. [16]
  H. Jadvar, Cancer Biother. Radiopharm. 35 (2020) 475–484. doi: 10.1089/cbr.2019.3340
17. [17]
  D.R. Corson, K.R. MacKenzie, E. Segrè, Phy. Rev. 58 (1940) 672–678. doi: 10.1103/PhysRev.58.672
18. [18]
  D.R. Corson, K.R. Mackenzie and E. Segre, Nature 159 (1947) 24. doi: 10.1038/159024b0
19. [19]
  G.J. Meyer, J. Labelled Compd. Radiopharm. 61 (2018) 154–164. doi: 10.1002/jlcr.3573
20. [20]
  J.R. Crawford, A.K.H. Robertson, H. Yang, et al., Phys. Med. Biol. 63 (2018) 045025. doi: 10.1088/1361-6560/aaaa95
21. [21]
  J.R. Crawford, P. Kunz, H. Yang, et al., Appl. Radiat. Isot. 122 (2017) 222–228. doi: 10.1016/j.apradiso.2017.01.035
22. [22]
  H. Ikeda, Y. Hayashi, N. Takahashi, et al., Appl. Radiat. Isot. 139 (2018) 251–255. doi: 10.1016/j.apradiso.2018.05.021
23. [23]
  D.H. Woen, C. Eiroa-Lledo, A.C. Akin, et al., Inorg. Chem. 59 (2020) 6137–6146. doi: 10.1021/acs.inorgchem.0c00221
24. [24]
  R.E. Vernon, J. Chem. Educ. 90 (2013) 1703–1707. doi: 10.1021/ed3008457
25. [25]
  A. Hermann, R. Hoffmann, N.W. Ashcroft, Phys. Rev. Lett. 111 (2013) 116404. doi: 10.1103/PhysRevLett.111.116404
26. [26]
  D. -D. Yang, F. Wang, Phys. Chem. Chem. Phys. 14 (2012) 15816–15825. doi: 10.1039/c2cp42108a
27. [27]
  B. Molina, J.R. Soto, J.J. Castro, Phys. Chem. Chem. Phys. 20 (2018) 11549–11553. doi: 10.1039/C8CP00494C
28. [28]
  D.S. Wilbur, Nat. Chem. 5 (2013) 246. doi: 10.1038/nchem.1580
29. [29]
  A. Serov, N. Aksenov, G. Bozhikov, et al., Radiochim. Acta 99 (2011) 593–599. doi: 10.1524/ract.2011.1850
30. [30]
  E. Aneheim, S. Palm, H. Jensen, et al., Sci. Rep. 9 (2019) 15900. doi: 10.1038/s41598-019-52365-5
31. [31]
  H. Kubo, K. Takahashi, S. Shimoyama, et al., Nucl. Med. Commun. 42 (2021) 1052–1059. doi: 10.1097/mnm.0000000000001430
32. [32]
  U. Lindencrona, L. Sillfors-Elverby, M. Nilsson, et al., Appl. Radiat. Isot. 62 (2005) 395–403. doi: 10.1016/j.apradiso.2004.07.004
33. [33]
  N. Guo, F. Pottier, J. Aupiais, et al., Inorg. Chem. 57 (2018) 4926–4933. doi: 10.1021/acs.inorgchem.7b03003
34. [34]
  J. Champion, C. Alliot, E. Renault, et al., J. Phys. Chem. A 114 (2010) 576–582. doi: 10.1021/jp9077008
35. [35]
  D.C. Sergentu, D. Teze, A. Sabatie-Gogova, et al., Chem. Eur. J. 22 (2016) 2964–2971. doi: 10.1002/chem.201504403
36. [36]
  J. Champion, A. Sabatie-Gogova, F. Bassal, et al., J. Phys. Chem. A 117 (2013) 1983–1990. doi: 10.1021/jp3099413
37. [37]
  N. Guo, D. -C. Sergentu, D. Teze, et al., Angew. Chem. Int. Ed. 55 (2016) 15369–15372. doi: 10.1002/anie.201608746
38. [38]
  I. Nishinaka, K. Hashimoto, H. Suzuki, J. Radioanal. Nucl. Chem, 318 (2018) 897–905. doi: 10.1007/s10967-018-6088-6
39. [39]
  J.G. Hill, X. Hu, Chem. Eur. J. 19 (2013) 3620–3628. doi: 10.1002/chem.201204312
40. [40]
  G.R. Desiraju, P.S. Ho, L. Kloo, et al., Pure Appl. Chem. 85 (2013) 1711–1713. doi: 10.1351/pac-rec-12-05-10
41. [41]
  N. Guo, R. Maurice, D. Teze, et al., Nat. Chem. 10 (2018) 428–434. doi: 10.1038/s41557-018-0011-1
42. [42]
  L. Liu, S. Rahali, R. Maurice, et al., Chem. Sci. 12 (2021) 10855–10861. doi: 10.1039/d1sc02133h
43. [43]
  L. Liu, N. Guo, J. Champion, et al., Chem. Eur. J. 26 (2020) 3713–3717. doi: 10.1002/chem.201905389
44. [44]
  F. Bassal, J. Champion, S. Pardoue, et al., Inorg. Chem. 59 (2020) 13923–13932. doi: 10.1021/acs.inorgchem.0c01553
45. [45]
  J. Champion, M. Seydou, A. Sabatie-Gogova, et al., Phys. Chem. Chem. Phys. 13 (2011) 14984–14992. doi: 10.1039/c1cp20512a
46. [46]
  J. Champion, C. Alliot, S. Huclier, et al., Inorg. Chim. Acta 362 (2009) 2654–2661. doi: 10.1016/j.ica.2008.12.005
47. [47]
  A. Borschevsky, L.F. Pasteka, V. Pershina, et al., Phys. Rev. A 91 (2015) 020501. doi: 10.1103/PhysRevA.91.020501
48. [48]
  Z. Chang, J. Li, C. Dong, J. Phys. Chem. A 114 (2010) 13388–13394. doi: 10.1021/jp107411s
49. [49]
  R. Si, C.F. Fischer, Phys. Rev. A 98 (2018) 052504. doi: 10.1103/PhysRevA.98.052504
50. [50]
  A. Shee, T. Saue, L. Visscher, et al., J. Chem. Phys. 149 (2018) 174113. doi: 10.1063/1.5053846
51. [51]
  W.A. Al-Saidi, J. Chem. Phys. 129 (2008) 064316. doi: 10.1063/1.2969098
52. [52]
  A.S. Pereira Gomes, F. Real, N. Galland, et al., Phys. Chem. Chem. Phys. 16 (2014) 9238–9248. doi: 10.1039/C3CP55294B
53. [53]
  K. Koziol, I. Agustin Aucar, G.A. Aucar, J. Chem. Phys. 150 (2019) 184301. doi: 10.1063/1.5095476
54. [54]
  K. Krause, W. Klopper, J. Chem. Phys. 139 (2013) 191102. doi: 10.1063/1.4832738
55. [55]
  C.G. Pech, P.A.B. Haase, N. Galland, et al., Phys. Rev. A 100 (2019) 032518. doi: 10.1103/PhysRevA.100.032518
56. [56]
  R. Maurice, F. Real, A.S.P. Gomes, et al., J. Chem. Phys. 142 (2015) 094305. doi: 10.1063/1.4913738
57. [57]
  M. Ponikvar-Svet, K.F. Edwards, J.F. Liebman, Struct. Chem. 32 (2021) 973–976. doi: 10.1007/s11224-021-01757-3
58. [58]
  J. Pilme, E. Renault, F. Bassal, et al., J. Chem. Theory Comput. 10 (2014) 4830–4841. doi: 10.1021/ct500762n
59. [59]
  A. Whiteside, S.S. Xantheas, M. Gutowski, Chem. Eur. J. 17 (2011) 13197–13205. doi: 10.1002/chem.201101949
60. [60]
  B. Senjean, S. Sen, M. Repisky, et al., J. Chem. Theory Comput., 17 (2021) 1337–1354. doi: 10.1021/acs.jctc.0c00964
61. [61]
  Y. Chamorro, E. Florez, A. Maldonado, et al., Int. J. Quantum Chem. 121 (2021) e26571.
62. [62]
  F. Real, A.S.P. Gomes, Y.O.G. Martinez, et al., J. Chem. Phys. 144 (2016) 124513. doi: 10.1063/1.4944613
63. [63]
  T. Ayed, M. Seydou, F. Real, et al., J. Phys. Chem. B 117 (2013) 5206–5211. doi: 10.1021/jp401759p
64. [64]
  T. Ayed, F. Real, G. Montavon, et al., J. Phys. Chem. B 117 (2013) 10589–10595. doi: 10.1021/jp406803e
65. [65]
  S. Sarr, J. Graton, S. Rahali, et al., Phys. Chem. Chem. Phys. 23 (2021) 4064–4074. doi: 10.1039/d0cp05840h
66. [66]
  E. Rossi, M. De Santis, D. Sorbelli, et al., Phys. Chem. Chem. Phys. 22 (2020) 1897–1910. doi: 10.1039/c9cp06293a
67. [67]
  S. Sarr, J. Graton, G. Montavon, et al., ChemPhysChem 21 (2020) 240–250. doi: 10.1002/cphc.201901023
68. [68]
  F. Zhou, Y. Liu, Z. Wang, et al., Phys. Chem. Chem. Phys. 21 (2019) 15310–15318. doi: 10.1039/c9cp02406a
69. [69]
  I. Alkorta, F. Blanco, M. Solimannejad, et al., J. Phys. Chem. A 112 (2008) 10856–10863. doi: 10.1021/jp806101t
70. [70]
  I. Alkorta, J. Elguero, M. Yanez, et al., Molecules 24 (2019) 4399. doi: 10.3390/molecules24234399
71. [71]
  N. Galland, G. Montavon, J.Y. Le Questel, et al., New J. Chem. 42 (2018) 10510–10517. doi: 10.1039/C8NJ00484F
72. [72]
  H. Kim, Y.J. Choi, Y.S. Lee, J. Phys. Chem. B 112 (2008) 16021–16029. doi: 10.1021/jp8056306
73. [73]
  C. Bae, Y.K. Han, Y.S. Lee, J. Phys. Chem. A 107 (2003) 852–858. doi: 10.1021/jp026531m
74. [74]
  M. Amaouch, D.C. Sergentu, D. Steinmetz, et al., J. Comput. Chem. 38 (2017) 2753–2762. doi: 10.1002/jcc.24905
75. [75]
  D.C. Sergentu, M. Amaouch, J. Pilme, et al., J. Chem. Phys. 143 (2015) 114306. doi: 10.1063/1.4930609
76. [76]
  D.C. Sergentu, G. David, G. Montavon, et al., J. Comput. Chem. 37 (2016) 1345–1354. doi: 10.1002/jcc.24326
77. [77]
  Y. Demidov, A. Zaitsevskii, Chem. Phys. Lett. 691 (2018) 126–130. doi: 10.1016/j.cplett.2017.11.008
78. [78]
  T. Ayed, J. Pilme, D. Teze, et al., Eur. J. Med. Chem. 116 (2016) 156–164. doi: 10.1016/j.ejmech.2016.03.082
79. [79]
  M. Amaouch, G. Montavon, N. Galland, et al., Mol. Phys. 114 (2016) 1326–1333. doi: 10.1080/00268976.2015.1120361
80. [80]
  D. Teze, D.C. Sergentu, V. Kalichuk, et al., Sci. Rep. 7 (2017) 2579. doi: 10.1038/s41598-017-02614-2
81. [81]
  W.A. Rabanal-Leon, W. Tiznado, L. Alvarez-Thon, Int. J. Quantum Chem. 119 (2019) e25859. doi: 10.1002/qua.25859
82. [82]
  R. Ramirez-Tagle, L. Alvarado-Soto, A. Villavicencio-Wastavino, et al., Phys. Chem. Chem. Phys. 18 (2016) 25751–25755. doi: 10.1039/C6CP05265G
83. [83]
  S. Rothe, A.N. Andreyev, S. Antalic, et al., Nat. Commun. 4 (2013) 1835. doi: 10.1038/ncomms2819
84. [84]
  D. Leimbach, J. Karls, Y. Guo, et al., Nat. Commun., 11 (2020) 3824. doi: 10.1038/s41467-020-17599-2
85. [85]
  Y. Feng, M.R. Zalutsky, Nucl. Med. Biol. 100-101 (2021) 12–23. doi: 10.1016/j.nucmedbio.2021.05.007
86. [86]
  J.D. Burns, E.E. Tereshatov, M.A. McCarthy, et al. Chem. Commun., 56 (2020) 9004–9007. doi: 10.1039/d0cc03804k
87. [87]
  J.D. Burns, E.E. Tereshatov, G. Avila, et al., Sep. Purif. Technol. 256 (2021) 117794. doi: 10.1016/j.seppur.2020.117794
88. [88]
  S. Watanabe, I. Sasaki, S. Watanabe, et al., J. Radioanal. Nucl. Chem. 326 (2020) 1399–1404. doi: 10.1007/s10967-020-07422-z
89. [89]
  Y. Li, D.K. Hamlin, M.K. Chyan, et al., Sci. Rep. 9 (2019) 16960. doi: 10.1038/s41598-019-53385-x
90. [90]
  M.J. O'Hara, A.J. Krzysko, D.K. Hamlin, et al., Sci. Rep. 9 (2019) 20318. doi: 10.1038/s41598-019-56272-7
91. [91]
  A. Orlova, O. Lebeda, V. Tolmachev, et al., J. Labelled Compd. Radiopharm. 43 (2000) 251–260. doi: 10.1002/(SICI)1099-1344(20000315)43:3<251::AID-JLCR311>3.0.CO;2-Z
92. [92]
  D.S. Wilbur, M.K. Chyan, D.K. Hamlin, et al., Bioconjug. Chem. 20 (2009) 591–602. doi: 10.1021/bc800515d
93. [93]
  D.S. Wilbur, M.S. Thakar, D.K. Hamlin, et al., Bioconjug. Chem. 20 (2009) 1983–1991. doi: 10.1021/bc9000799
94. [94]
  Y. Yang, R. Lin, N. Liu, et al., J. Radioanal. Nucl. Chem., 288 (2011) 71–77. doi: 10.1007/s10967-010-0872-2
95. [95]
  A. Sjostrom, V. Tolmachev, O. Lebeda, et al., J. Radioanal. Nucl. Chem. 256 (2003) 191–197. doi: 10.1023/A:1023912728929
96. [96]
  D.S. Wilbur, M.K. Chyan, D.K. Hamlin, et al., Bioconjug. Chem. 15 (2004) 203–223. doi: 10.1021/bc034175k
97. [97]
  D.S. Wilbur, D.K. Hamlin, M.K. Chyan, et al., Bioconjug. Chem. 15 (2004) 601–616. doi: 10.1021/bc034229q
98. [98]
  D.S. Wilbur, M.K. Chyan, D.K. Hamlin, et al., Bioconjug. Chem. 18 (2007) 1226–1240. doi: 10.1021/bc060345s
99. [99]
  D.S. Wilbur, M.K. Chyan, D.K. Hamlin, et al., Nucl. Med. Biol. 37 (2010) 167–178. doi: 10.1016/j.nucmedbio.2009.10.004
100. [100]
  F. Guerard, C. Maingueneau, L. Liu, et al., Acc. Chem. Res. 54 (2021) 3264–3275. doi: 10.1021/acs.accounts.1c00327
101. [101]
  A.T. Yordanov, K. Deal, K. Garmestani, et al., J. Labelled Compd. Radiopharm. 43 (2000) 1219–1225. doi: 10.1002/1099-1344(20001030)43:12<1219::AID-JLCR409>3.0.CO;2-P
102. [102]
  M. Lyczko, M. Pruszynski, A. Majkowska-Pilip, et al., Nucl. Med. Biol. 53 (2017) 1–8. doi: 10.1016/j.nucmedbio.2017.05.008
103. [103]
  H. Rajerison, F. Guerard, M. Mougin-Degraef, et al., Nucl. Med. Biol. 41 (2014) E23–E29. doi: 10.1016/j.nucmedbio.2013.12.004
104. [104]
  M. Pruszynski, M. Lyczko, A. Bilewicz, et al., Nucl. Med. Biol. 42 (2015) 439–445. doi: 10.1016/j.nucmedbio.2014.12.011
105. [105]
  M. Pruszynski, A. Bilewicz and M.R. Zalutsky, Bioconjug. Chem. 19 (2008) 958–965. doi: 10.1021/bc700413r
106. [106]
  C. Denk, M. Wilkovitsch, E. Aneheim, et al., Chempluschem 84 (2019) 775–778. doi: 10.1002/cplu.201900114
107. [107]
  M. Berdal, S. Gouard, R. Eychenne, et al., Chem. Sci. 12 (2021) 1458–1468. doi: 10.1039/d0sc05191h
108. [108]
  S.W. Reilly, M. Makvandi, K. Xu, et al., Org. Lett. 20 (2018) 1752–1755. doi: 10.1021/acs.orglett.8b00232
109. [109]
  Y. Shirakami, T. Watabe, H. Obata, et al., Sci. Rep. 11 (2021) 12982. doi: 10.1038/s41598-021-92476-6
110. [110]
  S. Ostrowski, A. Majkowska-Pilip, A. Bilewicz, et al., RSC Adv. 7 (2017) 35854–35857. doi: 10.1039/C7RA05224C
111. [111]
  E. Cedrowska, M. Lyczko, A. Piotrowska, et al., Radiochim. Acta 104 (2016) 267–275. doi: 10.1515/ract-2014-2373
112. [112]
  S. Lindegren, S. Frost, T. Baeck, et al., J. Nucl. Med. 49 (2008) 1537–1545. doi: 10.2967/jnumed.107.049833
113. [113]
  E. Aneheim, J. Hallerod, P. Albertsson, et al., Cancer Biother. Radiopharm. 30 (2015) 41–45. doi: 10.1089/cbr.2014.1729
114. [114]
  V.S. Talanov, K. Garmestani, C.A.S. Regino, et al., Nucl. Med. Biol. 33 (2006) 469–480. doi: 10.1016/j.nucmedbio.2006.03.001
115. [115]
  A.T. Yordanov, K. Garmestani, M. Zhang, et al., Nucl. Med. Biol. 28 (2001) 845–856. doi: 10.1016/S0969-8051(01)00257-8
116. [116]
  E. Aneheim, M.R.S. Foreman, H. Jensen, et al., Appl. Radiat. Isot. 96 (2015) 1–5. doi: 10.1016/j.apradiso.2014.11.007
117. [117]
  E. Aneheim, A. Gustafsson, P. Albertsson, et al., Bioconjug. Chem. 27 (2016) 688–697. doi: 10.1021/acs.bioconjchem.5b00664
118. [118]
  D.S. Wilbur, M.K. Chyan, H. Nakamae, et al., Bioconjug. Chem. 23 (2012) 409–420. doi: 10.1021/bc200401b
119. [119]
  K. Ogawa, T. Takeda, K. Mishiro, et al., Acs Omega 4 (2019) 4584–4591. doi: 10.1021/acsomega.8b03679
120. [120]
  V.S. Talanov, A.T. Yordanov, K. Garmestani, et al., Nucl. Med. Biol. 31 (2004) 1061–1071. doi: 10.1016/j.nucmedbio.2004.08.005
121. [121]
  G. Vaidyanathan, D.J. Affleck, D.D. Bigner, et al., Nucl. Med. Biol. 30 (2003) 351–359. doi: 10.1016/S0969-8051(03)00005-2
122. [122]
  G. Vaidyanathan, D.J. Affleck, K.L. Alston, et al., Bioorg. Med. Chem. 15 (2007) 3430–3436. doi: 10.1016/j.bmc.2007.03.016
123. [123]
  G. Vaidyanathan, D.J. Affleck, K.L. Alston, et al., J. Labelled Compd. Radiopharm. 50 (2007) 177–182. doi: 10.1002/jlcr.1243
124. [124]
  Y. Dekempeneer, T. Back, E. Aneheim, et al., Mol. Pharm. 16 (2019) 3524–3533. doi: 10.1021/acs.molpharmaceut.9b00354
125. [125]
  O.R. Pozzi, M.R. Zalutsky, J. Nucl. Med., 46 (2005) 700–706.
126. [126]
  G. Vaidyanathan, O.R. Pozzi, J. Choi, et al., Cancer Biother. Radiopharm. 35 (2020) 511–519. doi: 10.1089/cbr.2019.3204
127. [127]
  O.R. Pozzi, M.R. Zalutsky, J. Nucl. Med. 48 (2007) 1190–1196. doi: 10.2967/jnumed.106.038505
128. [128]
  S. Lindegren, H. Andersson, T. Back, et al., Nucl. Med. Biol. 28 (2001) 33–39. doi: 10.1016/S0969-8051(00)00171-2
129. [129]
  O.R. Pozzi and M.R. Zalutsky, Nucl. Med. Biol. 46 (2017) 43–49. doi: 10.1016/j.nucmedbio.2016.11.009
130. [130]
  M.R. Zalutsky, X.G. Zhao, K.L. Alston, et al., J. Nucl. Med. 42 (2001) 1508–1515.
131. [131]
  E. Aneheim, P. Albertsson, T. Back, et al., Sci. Rep. 5 (2015) 12025. doi: 10.1038/srep12025
132. [132]
  E. Aneheim, H. Jensen, P. Albertsson, et al., J. Radioanal. Nucl. Chem. 303 (2015) 979–983. doi: 10.1007/s10967-014-3561-8
133. [133]
  Y. Li, D.K. Hamlin, M.K. Chyan, et al., PLoS One 13 (2018) e0205135. doi: 10.1371/journal.pone.0205135
134. [134]
  H. Takagi, S. Zhao, S. Muto, et al., Lung Cancer 153 (2021) 134–142. doi: 10.1016/j.lungcan.2021.01.014
135. [135]
  H. Ma, F. Li, G. Shen, et al., Mol. Pharm. 18 (2021) 4179–4187. doi: 10.1021/acs.molpharmaceut.1c00566
136. [136]
  J.M. Kelly, A. Amor-Coarasa, A. Nikolopoulou, et al., J. Nucl. Med. 58 (2017) 1442–1449. doi: 10.2967/jnumed.116.188722
137. [137]
  Y. Li, M.K. Chyan, D.K. Hamlin, et al., Nucl. Med. Biol. 92 (2021) 217–227. doi: 10.1016/j.nucmedbio.2020.04.005
138. [138]
  A.C. Steffen, Y. Almqvist, M.K. Chyan, et al., Oncol. Rep. 17 (2007) 1141–1147. doi: 10.3892/or.17.5.1141
139. [139]
  D.S. Wilbur, M.K. Chyan, D.K. Hamlin, et al., Bioconjug. Chem. 22 (2011) 1089–1102. doi: 10.1021/bc1005625
140. [140]
  E. Dadachova, N. Carrasco, Semin. Nucl. Med. 34 (2004) 23–31. doi: 10.1053/j.semnuclmed.2003.09.004
141. [141]
  S. Carlin, R.J. Mairs, P. Welsh, et al., Nucl. Med. Biol. 29 (2002) 729–739. doi: 10.1016/S0969-8051(02)00332-3
142. [142]
  U. Lindencrona, M. Nilsson, E. Forssell-Aronsson, Nucl. Med. Biol. 28 (2001) 41–50. doi: 10.1016/S0969-8051(00)00179-7
143. [143]
  O.A. Yuminov, V.A. Drozdov, D.A. Bondarenko, et al., Mosc. Univ. Phy. Bull. 73 (2018) 401–404. doi: 10.3103/s002713491804015x
144. [144]
  U. Lindencrona, E. Forssell-Aronsson, M. Nilsson, Nucl. Med. Biol. 34 (2007) 523–530. doi: 10.1016/j.nucmedbio.2007.03.012
145. [145]
  T. Petrich, H.J. Helmeke, G.J. Meyer, et al., Eur. J. Nucl. Med. Mol. Imaging 29 (2002) 842–854. doi: 10.1007/s00259-002-0784-7
146. [146]
  T. Unak, Appl. Radiat. Isot. 58 (2003) 115–117. doi: 10.1016/S0969-8043(02)00260-9
147. [147]
  A. Danielsson, K. Claesson, T.Z. Parris, et al., Int. J. Radiat. Biol. 89 (2013) 250–258. doi: 10.3109/09553002.2013.746751
148. [148]
  E. Aurlien, Y. Kvinnsland, R.H. Larsen, et al., Int. J. Radiat. Biol. 78 (2002) 133–142. doi: 10.1080/09553000110094788
149. [149]
  E.A. Dashko, E.V. Kizhaev, O.A. Yuminov, et al., Bullet. Russ. Acad. Sci. Phy. 74 (2010) 1591–1594. doi: 10.3103/S1062873810110201
150. [150]
  C. Lundh, U. Lindencrona, P. Postgard, et al., J. Nucl. Med., 50 (2009) 1161–1167. doi: 10.2967/jnumed.108.061150
151. [151]
  J. Kotzerke, M. Wendisch, R. Freudenberg, et al., Nuklearmedizin-Nuclear Med. 51 (2012) 170–178. doi: 10.3413/Nukmed-0506-12-05
152. [152]
  N. Rudqvist, T.Z. Parris, E. Schuler, et al., EJNMMI Res. 2 (2012) 32. doi: 10.1186/2191-219X-2-32
153. [153]
  N. Rudqvist, J. Spetz, E. Schuler, et al., PLoS One 10 (2015) e0131686. doi: 10.1371/journal.pone.0131686
154. [154]
  B. Langen, N. Rudqvist, T.Z. Parris, et al., J. Nucl. Med. 54 (2013) 990–998. doi: 10.2967/jnumed.112.114462
155. [155]
  B. Langen, N. Rudqvist, T.Z. Parris, et al., EJNMMI Res. 5 (2015) 1. doi: 10.1186/s13550-014-0078-7
156. [156]
  O.V. Fotina, T.V. Gulyaeva, V.A. Drozdov, et al., B Bullet. Russ. Acad. Sci. Phy. 79 (2015) 458–460. doi: 10.3103/S1062873815040097
157. [157]
  T. Petrich, L. Quintanilla-Martinez, Z. Korkmaz, et al., Clin. Cancer Res. 12 (2006) 1342–1348. doi: 10.1158/1078-0432.CCR-05-1576
158. [158]
  M.J. Willhauck, B.R.S. Samani, I. Wolf, et al., Eur. J. Nucl. Med. Mol. Imaging 35 (2008) 1272–1281. doi: 10.1007/s00259-008-0775-4
159. [159]
  S. Carlin, G. Akabani, M.R. Zalutsky, J. Nucl. Med. 44 (2003) 1827–1838. doi: 10.1016/S0378-4371(01)00554-4
160. [160]
  J. Spetz, N. Rudqvist, E. Forssell-Aronsson, Cancer Biother. Radiopharm. 28 (2013) 657–664. doi: 10.1089/cbr.2013.1483
161. [161]
  C. Lundh, U. Lindencrona, A. Schmitt, et al., Cancer Biother. Radiopharm. 21 (2006) 591–600. doi: 10.1089/cbr.2006.21.591
162. [162]
  B. Langen, N. Rudqvist, K. Helou, et al., J. Nucl. Med. 58 (2017) 346–353. doi: 10.2967/jnumed.116.176958
163. [163]
  Y. Liu, T. Watabe, K. Kaneda-Nakashima, et al., Transl. Oncol. 13 (2020) 100757. doi: 10.1016/j.tranon.2020.100757
164. [164]
  T. Watabe, K. Kaneda-Nakashima, K. Ooe, et al., Ann. Nucl. Med. 35 (2021) 702–718. doi: 10.1007/s12149-021-01612-9
165. [165]
  D. Kayano, S. Kinuya, Nucl. Med. Mol. Imaging 52 (2018) 254–265. doi: 10.1007/s13139-018-0523-z
166. [166]
  G. Vaidyanathan, M.R. Zalutsky, Bioconjug. Chem. 3 (1992) 499–503. doi: 10.1021/bc00018a006
167. [167]
  G. Vaidyanathan, D.K. Strickland, M.R. Zalutsky, Int. J. Cancer 57 (1994) 908–913. doi: 10.1002/ijc.2910570622
168. [168]
  D.K. Strickland, G. Vaidyanathan, H.S. Friedman, et al., J. Neurooncol. 25 (1995) 9–17. doi: 10.1007/BF01054718
169. [169]
  R.E. McLendon, G.E. Archer, P.K. Garg, et al., Int. J. Radiat. Oncol. Biol. Phys. 35 (1996) 69–80. doi: 10.1016/S0360-3016(96)85013-9
170. [170]
  G. Vaidyanathan, D.J. Affleck, M.R. Zalutsky, Bioconjug. Chem., 7 (1996) 102–107. doi: 10.1021/bc950078i
171. [171]
  G. Vaidyanathan, H.S. Friedman, S.T. Keir, et al., Nucl. Med. Biol. 23 (1996) 851–856. doi: 10.1016/0969-8051(96)00115-1
172. [172]
  G. Vaidyanathan, X.G. Zhao, R.H. Larsen, et al., Br. J. Cancer 76 (1997) 226–233. doi: 10.1038/bjc.1997.366
173. [173]
  S.H. Cunningham, R.J. Mairs, T.E. Wheldon, et al., Br. J. Cancer 77 (1998) 2061–2068. doi: 10.1038/bjc.1998.348
174. [174]
  M. Boyd, R.J. Mairs, W.N. Keith, et al., J. Gene Med. 6 (2004) 937–947. doi: 10.1002/jgm.578
175. [175]
  M. Boyd, S.C. Ross, J. Dorrens, et al., J. Nucl. Med. 47 (2006) 1007–1015. doi: 10.1016/S0150-9861(06)77546-0
176. [176]
  Y. Ohshima, H. Sudo, S. Watanabe, et al., Eur. J. Nucl. Med. Mol. Imaging 45 (2018) 999–1010. doi: 10.1007/s00259-017-3919-6
177. [177]
  H. Sudo, A.B. Tsuji, A. Sugyo, et al., Transl. Oncol. 12 (2019) 879–888. doi: 10.1016/j.tranon.2019.04.008
178. [178]
  G.J. Meyer, A. Walte, S.R. Sriyapureddy, et al., Appl. Radiat. Isot. 68 (2010) 1060–1065. doi: 10.1016/j.apradiso.2009.12.043
179. [179]
  T. Watabe, K. Kaneda-Nakashima, Y. Shirakami, et al., Oncotarget 11 (2020) 1388–1398. doi: 10.18632/oncotarget.27552
180. [180]
  N. Borrmann, S. Friedrich, K. Schwabe, et al., Nuklearmedizin-Nuclear Med. 52 (2013) 212–221. doi: 10.3413/Nukmed-0580-13-05
181. [181]
  Y. Ohshima, H. Suzuki, H. Hanaoka, et al., Nucl. Med. Biol. 90-91 (2020) 15–22. doi: 10.1016/j.nucmedbio.2020.08.003
182. [182]
  L. Xie, M. Hanyu, M. Fujinaga, et al., J. Nucl. Med. 61 (2020) 242–248. doi: 10.2967/jnumed.119.230946
183. [183]
  K. Kaneda-Nakashima, Z. Zhang, Y. Manabe, et al., Cancer Sci. 112 (2021) 1132–1140. doi: 10.1111/cas.14761
184. [184]
  M. Makvandi, H. Lee, L.N. Puentes, et al., Mol. Cancer Ther. 18 (2019) 1195–1204. doi: 10.1158/1535-7163.mct-18-0837
185. [185]
  H. Dabagian, T. Taghvaee, P. Martorano, et al., ACS Pharmacol. Transl. Sci. 4 (2021) 344–351. doi: 10.1021/acsptsci.0c00206
186. [186]
  A.P. Kiess, I. Minn, G. Vaidyanathan, et al., J. Nucl. Med. 57 (2016) 1569–1575. doi: 10.2967/jnumed.116.174300
187. [187]
  G. Vaidyanathan, R.C. Mease, I. Minn, et al., Nucl. Med. Biol. 94-95 (2021) 67–80. doi: 10.1016/j.nucmedbio.2021.01.002
188. [188]
  R.C. Mease, C. Kang, V. Kumar, et al., J. Nucl. Med. 63 (2021) 259–267. doi: 10.1016/S0150-9861(06)77546-0
189. [189]
  H. Ma, F. Li, G. Shen, et al., Bioorg. Med. Chem. 55 (2022) 116600. doi: 10.1016/j.bmc.2021.116600
190. [190]
  E. Dadachova, Semin. Nucl. Med. 40 (2010) 204–208. doi: 10.1053/j.semnuclmed.2010.01.002
191. [191]
  G. Vaidyanathan, D. Affleck, P. Welsh, et al., Nucl. Med. Biol. 27 (2000) 329–337. doi: 10.1016/S0969-8051(00)00098-6
192. [192]
  G. Vaidyanathan, A. Boskovitz, S. Shankar, et al., Peptides 25 (2004) 2087–2097. doi: 10.1016/j.peptides.2004.08.018
193. [193]
  G. Vaidyanathan, D.J. Affleck, M. Schottelius, et al., Bioconjug. Chem. 17 (2006) 195–203. doi: 10.1021/bc0502560
194. [194]
  B. Zhao, S. Qin, L. Chai, et al., Bioorg. Med. Chem. 26 (2018) 1086–1091. doi: 10.1016/j.bmc.2018.01.023
195. [195]
  M. Aoki, S. Zhao, K. Takahashi, et al., Chem. Pharm. Bull. 68 (2020) 538–545. doi: 10.1248/cpb.c20-00077
196. [196]
  W. Liu, Y. Tang, H. Ma, et al., Radiochim. Acta 109 (2021) 119–126. doi: 10.1515/ract-2020-0016
197. [197]
  W. Liu, H. Ma, Y. Tang, et al., J. Radioanal. Nucl. Chem. 316 (2018) 451–456. doi: 10.1007/s10967-018-5780-x
198. [198]
  A. Rondon, J. Rouanet, F. Degoul, Cancers 13 (2021), 5570. doi: 10.3390/cancers13215570
199. [199]
  N. Liu, J. Jin, S. Zhang, et al., J. Radioanal. Nucl. Chem. 247 (2001) 129–133. doi: 10.1023/A:1006727401721
200. [200]
  N. Liu, Y. Yang, L. Zan, et al., J. Radioanal. Nucl. Chem. 272 (2007) 85–90. doi: 10.1007/s10967-006-6781-8
201. [201]
  S.J. Kennel, S. Mirzadeh, W.C. Eckelman, et al., Radiat. Res. 157 (2002) 633–641. doi: 10.1667/0033-7587(2002)157[0633:VTRWTA]2.0.CO;2
202. [202]
  G. Akabani, S.J. Kennel, M.R. Zalutsky, J. Nucl. Med. 44 (2003) 792–805.
203. [203]
  M.I. Persson, L. Gedda, H.J. Jensen, et al., Oncol. Rep. 15 (2006) 673–680.
204. [204]
  G. Akabani, S. Carlin, P. Welsh, et al., Nucl. Med. Biol. 33 (2006) 333–347. doi: 10.1016/j.nucmedbio.2005.12.006
205. [205]
  A. Boskovitz, R.E. McLendon, T. Okamura, et al., Nucl. Med. Biol. 36 (2009) 659–669. doi: 10.1016/j.nucmedbio.2009.04.003
206. [206]
  S. Palm, T. Back, I. Claesson, et al., Int. J. Radiat. Oncol. Biol. Phys. 69 (2007) 572–579. doi: 10.1016/j.ijrobp.2007.06.023
207. [207]
  S. Kodaira, H.K. Li, T. Konishi, et al., PLoS One 12 (2017) e0178472. doi: 10.1371/journal.pone.0178472
208. [208]
  H.K. Li, Y. Morokoshi, K. Nagatsu, et al., Cancer Sci. 108 (2017) 1648–1656. doi: 10.1111/cas.13282
209. [209]
  S. Kodaira, Y. Morokoshi, H.K. Li, et al., J. Nucl. Med. 60 (2019) 497–501. doi: 10.2967/jnumed.118.216853
210. [210]
  H.K. Li, Y. Morokoshi, S. Kodaira, et al., J. Nucl. Med. 62 (2021) 1468–1474. doi: 10.2967/jnumed.120.249300
211. [211]
  E. Cederkrantz, E. Angenete, T. Back, et al., Cancer Biother. Radiopharm. 27 (2012) 353–364. doi: 10.1089/cbr.2012.1184
212. [212]
  H. Andersson, S. Lindegren, T. Back, et al., Acta Oncol. 39 (2000) 741–745. doi: 10.1080/028418600750063820
213. [213]
  H. Andersson, S. Lindegren, T. Back, et al., Anticancer Res. 20 (2000) 459–462.
214. [214]
  T. Back, H. Andersson, C.R. Divgi, et al., J. Nucl. Med. 46 (2005) 2061–2067.
215. [215]
  J. Elgqvist, H. Andersson, P. Bernhardt, et al., Int. J. Radiat. Oncol. Biol. Phys. 66 (2006) 1228–1237. doi: 10.1016/j.ijrobp.2006.07.003
216. [216]
  J. Elgqvist, P. Bernhardt, R. Hultborn, et al., J. Nucl. Med. 46 (2005) 464–471.
217. [217]
  S. Palm, T. Back, S. Lindegren, et al., J. Nucl. Med. 59 (2018) 646–651. doi: 10.2967/jnumed.117.201285
218. [218]
  J. Elgqvist, H. Andersson, T. Baeck, et al., J. Nucl. Med., 47 (2006) 1342–1350.
219. [219]
  J. Elgqvist, B.R. Johansson, K. Partheen, et al., Anticancer Res. 30 (2010) 2545–2551. doi: 10.1097/CAD.0b013e32833ab7a0
220. [220]
  J. Elgqvist, H. Andersson, T. Back, et al., Nucl. Med. Biol. 33 (2006) 1065–1072. doi: 10.1016/j.nucmedbio.2006.07.009
221. [221]
  T. Back, N. Chouin, S. Lindegren, et al., J. Nucl. Med. 58 (2017) 598–604. doi: 10.2967/jnumed.116.178327
222. [222]
  J. Elgqvist, H. Andersson, E. Haglund, et al., Cancer Biother. Radiopharm. 24 (2009) 509–513. doi: 10.1089/cbr.2009.0618
223. [223]
  J. Elgqvist, D. Ahlberg, H. Andersson, et al., World J. Oncol. 1 (2010) 101–110.
224. [224]
  A.M.E. Gustafsson, T. Back, J. Elgqvist, et al., Nucl. Med. Biol. 39 (2012) 15–22. doi: 10.1016/j.nucmedbio.2011.07.003
225. [225]
  N. Chouin, S. Lindegren, S.H.L. Frost, et al., J. Nucl. Med. 54 (2013) 1347–1353. doi: 10.2967/jnumed.112.113001
226. [226]
  T. Back, B. Haraldsson, R. Hultborn, et al., Cancer Biother. Radiopharm. 24 (2009) 649–658. doi: 10.1089/cbr.2009.0628
227. [227]
  S. Lindegren, L.N.S. Andrade, T. Back, et al., PLoS One 10 (2015) e0126298. doi: 10.1371/journal.pone.0126298
228. [228]
  S. Palm, T. Back, E. Aneheim, et al., Transl. Oncol. 14 (2021) 100873. doi: 10.1016/j.tranon.2020.100873
229. [229]
  E. Aurlien, R.H. Larsen, G. Kvalheim, et al., Br. J. Cancer 83 (2000) 1375–1379. doi: 10.1054/bjoc.2000.1453
230. [230]
  J.N. Wesley, E.C. McGee, K. Garmestani, et al., Nucl. Med. Biol. 31 (2004) 357–364. doi: 10.1016/j.nucmedbio.2003.08.011
231. [231]
  M. Zhang, Z. Yao, Z. Zhang, et al., Cancer Res. 66 (2006) 8227–8232. doi: 10.1158/0008-5472.CAN-06-1189
232. [232]
  Z.S. Yao, K. Garmestani, K.J. Wong, et al., J. Nucl. Med. 42 (2001) 1538–1544.
233. [233]
  Z. Zhang, M. Zhang, K. Garmestani, et al., Blood 108 (2006) 1007–1012. doi: 10.1182/blood-2005-11-4757
234. [234]
  H. Nakamae, D.S. Wilbur, D.K. Hamlin, et al., Cancer Res. 69 (2009) 2408–2415. doi: 10.1158/0008-5472.CAN-08-4363
235. [235]
  J.J. Orozco, T. Baeck, A. Kenoyer, et al., Blood 121 (2013) 3759–3767. doi: 10.1182/blood-2012-11-467035
236. [236]
  Y. Chen, B. Kornblit, D.K. Hamlin, et al., Blood 119 (2012) 1130–1138. doi: 10.1182/blood-2011-09-380436
237. [237]
  C.R. Burtner, D. Chandrasekaran, E.B. Santos, et al., Hum. Gene Ther. 26 (2015) 399–406. doi: 10.1089/hum.2015.021
238. [238]
  S.H.L. Frost, B.W. Miller, T.A. Baeck, et al., J. Nucl. Med. 56 (2015) 1766–1773. doi: 10.2967/jnumed.115.162388
239. [239]
  A. Nakaya, H. Qiu, E.B. Santos, et al., Transplant. Cell. Ther. 27 (2021) 476. e1-476. e7. doi: 10.1016/j.jtct.2021.02.018
240. [240]
  T. Petrich, Z. Korkmaz, D. Krull, et al., Eur. J. Nucl. Med. Mol. Imaging 37 (2010) 851–861. doi: 10.1007/s00259-009-1356-x
241. [241]
  A. Walte, S. Sriyapureddy, D. Krull, et al., Nuklearmedizin-Nuclear Med. 50 (2011) 214–220. doi: 10.3413/nukmed-0385-11-02
242. [242]
  S. O'Steen, M.L. Comstock, J.J. Orozco, et al., Blood 134 (2019) 1247–1256. doi: 10.1182/blood.2019001250
243. [243]
  S. Gouard, C. Maurel, S. Marionneau-Lambot, et al., Cancers 12 (2020) 2721. doi: 10.3390/cancers12092721
244. [244]
  M. Nestor, M. Persson, G. van Dongen, et al., Eur. J. Nucl. Med. Mol. Imaging 32 (2005) 1296–1304. doi: 10.1007/s00259-005-1848-2
245. [245]
  J. Cheng, T. Ekberg, M. Engstrom, et al., Laryngoscope 117 (2007) 1013–1018. doi: 10.1097/MLG.0b013e31804b1a6d
246. [246]
  M.K. Robinson, C. Shaller, K. Garmestani, et al., Clin. Cancer Res. 14 (2008) 875–882. doi: 10.1158/1078-0432.CCR-07-1250
247. [247]
  A. Turtoi, I. Brown, M. Schlaeger, et al., Radiat. Res. 174 (2010) 125–136. doi: 10.1667/RR1659.1
248. [248]
  A. Turtoi, F.H.A. Schneeweiss, Int. J. Radiat. Biol. 85 (2009) 403–412. doi: 10.1080/09553000902838541
249. [249]
  D.J. Green, M. Shadman, J.C. Jones, et al., Blood 125 (2015) 2111–2119. doi: 10.1182/blood-2014-11-612770
250. [250]
  T.A. Back, K. Jennbacken, M.H. Thulin, et al., EJNMMI Res. 10 (2020) 10. doi: 10.1186/s13550-020-0600-z
251. [251]
  S.E. Eriksson, T. Back, E. Elgstrom, et al., EJNMMI Res. 3 (2013) 23. doi: 10.1186/2191-219X-3-23
252. [252]
  H.K. Li, S. Hasegawa, N.I. Nakajima, et al., Biochem. Biophys. Res. Commun. 506 (2018) 1078–1084. doi: 10.1016/j.bbrc.2018.10.157
253. [253]
  H.K. Li, A. Sugyo, A.B. Tsuji, et al., Cancer Sci. 109 (2018) 2302–2309. doi: 10.1111/cas.13636
254. [254]
  S.E. Eriksson, E. Elgstrom, T. Back, et al., Cancer Biother. Radiopharm. 29 (2014) 238–246. doi: 10.1089/cbr.2014.1625
255. [255]
  A.L. Sundberg, A.C. Steffen, Int. J. Radiat. Oncol. Biol. Phys., 67 (2007) 279–287. doi: 10.1016/j.ijrobp.2006.07.1369
256. [256]
  H. Takashima, Y. Koga, S. Manabe, et al., Cancer Sci. 112 (2021) 1975–1986. doi: 10.1111/cas.14857
257. [257]
  D.S. Wilbur, D.K. Hamlin, M.K. Chyan, et al., Bioconjug. Chem. 19 (2008) 158–170. doi: 10.1021/bc7002428
258. [258]
  S.H.L. Frost, T. Back, N. Chouin, et al., Cancer Biother. Radiopharm. 26 (2011) 727–736. doi: 10.1089/cbr.2011.1046
259. [259]
  S.H.L. Frost, H. Jensen, S. Lindegren, Cancer 116 (2010) 1101–1110. doi: 10.1002/cncr.24798
260. [260]
  S.H.L. Frost, T. Back, N. Chouin, et al., Cancer Biother. Radiopharm. 28 (2013) 108–114. doi: 10.1089/cbr.2012.1281
261. [261]
  L. Navarro, M. Berdal, M. Cherel, et al., Bioorg. Med. Chem. 27 (2019) 167–174. doi: 10.1016/j.bmc.2018.11.034
262. [262]
  M. Nestor, M. Sundstroem, M. Anniko, et al., Nucl. Med. Biol. 38 (2011) 103–112. doi: 10.1016/j.nucmedbio.2010.06.014
263. [263]
  A.L. Sundberg, Y. Almqvist, V. Tolmachev, et al., Eur. J. Nucl. Med. Mol. Imaging 30 (2003) 727–729. doi: 10.1007/s00259-003-1129-x
264. [264]
  A.L. Sundberg, Y. Almqvist, A. Orlova, et al., Eur. J. Nucl. Med. Mol. Imaging 30 (2003) 1348–1356. doi: 10.1007/s00259-003-1308-9
265. [265]
  J.B. Pasternack, J.D. Domogauer, A. Khullar, et al., J. Nucl. Med. 55 (2014) 2012–2019. doi: 10.2967/jnumed.114.141580
266. [266]
  Y. Almqvist, A. Orlova, A. Sjostrom, et al., Cancer Biother. Radiopharm. 20 (2005) 514–523. doi: 10.1089/cbr.2005.20.514
267. [267]
  S. Demartis, L. Tarli, L. Borsi, et al., Eur. J. Nucl. Med. 28 (2001) 534–539. doi: 10.1007/s002590100480
268. [268]
  Y. Almqvist, A.C. Steffen, H. Lundqvist, et al., Cancer Biother. Radiopharm. 22 (2007) 480–487. doi: 10.1089/cbr.2007.349A
269. [269]
  A.A. Rosenkranz, G. Vaidyanathan, O.R. Pozzi, et al., Int. J. Radiat. Oncol. Biol. Phys. 72 (2008) 193–200. doi: 10.1016/j.ijrobp.2008.05.055
270. [270]
  J. Choi, G. Vaidyanathan, E. Koumarianou, et al., Nucl. Med. Biol. 56 (2018) 10–20. doi: 10.1016/j.nucmedbio.2017.09.003
271. [271]
  X. Wang, W. Ma, W. Liu, et al., J. Radiat. Res. 61 (2020) 684–690. doi: 10.1093/jrr/rraa049
272. [272]
  N. Oriuchi, M. Aoki, N. Ukon, et al., Sci. Rep. 10 (2020) 6810. doi: 10.1038/s41598-020-63557-9
273. [273]
  A. Orlova, A. Sjostrom, O. Lebeda, et al., Anticancer Res. 24 (2004) 4035–4041. doi: 10.1097/00001813-200411000-00010
274. [274]
  J. Kucka, M. Hruby, C. Konak, et al., Appl. Radiat. Isot. 64 (2006) 201–206. doi: 10.1016/j.apradiso.2005.07.021
275. [275]
  K.B. Hartman, D.K. Hamlin, D.S. Wilbur, et al., Small 3 (2007) 1496–1499. doi: 10.1002/smll.200700153
276. [276]
  L. Dziawer, P. Kozminski, S. Meczynska-Wielgosz, et al., RSC Adv. 7 (2017) 41024–41032. doi: 10.1039/C7RA06376H
277. [277]
  E. Sporer, C.B.M. Poulie, S. Lindegren, et al., J. Nanotheranostics 2 (2021) 196–207. doi: 10.3390/jnt2040012
278. [278]
  H. Kato, X. Huang, Y. Kadonaga, et al., J. Nanobiotechnology 19 (2021) 223. doi: 10.1186/s12951-021-00963-9
279. [279]
  Y. Liu, Z. Zhou, Y. Feng, et al., Int. J. Nanomedicine 16 (2021) 7297–7305. doi: 10.2147/ijn.s327577
280. [280]
  X. Shi, Q. Li, L. Zhang, et al., Bioconjug. Chem. 32 (2021) 1763–1772. doi: 10.1021/acs.bioconjchem.1c00263
281. [281]
  G. Akabani, R.E. McLendon, D.D. Bigner, et al., Int. J. Radiat. Oncol. Biol. Phys. 54 (2002) 1259–1275. doi: 10.1016/S0360-3016(02)03794-X
282. [282]
  M.R. Zalutsky, D.A. Reardon, G. Akabani, et al., J. Nucl. Med. 49 (2008) 30–38. doi: 10.2967/jnumed.107.046938
283. [283]
  H. Andersson, E. Cederkrantz, T. Back, et al., J. Nucl. Med. 50 (2009) 1153–1160. doi: 10.2967/jnumed.109.062604
284. [284]
  E. Cederkrantz, H. Andersson, P. Bernhardt, et al., Int. J. Radiat. Oncol. Biol. Phys. 93 (2015) 569–576. doi: 10.1016/j.ijrobp.2015.07.005
285. [285]
  A. Hallqvist, K. Bergmark, T. Back, et al., J. Nucl. Med. 60 (2019) 1073–1079. doi: 10.2967/jnumed.118.220384
286. [286]
  F. Guerard, L. Navarro, Y.S. Lee, et al., Bioorg. Med. Chem. 25 (2017) 5975–5980. doi: 10.1016/j.bmc.2017.09.022
1. [1]
  Dan Ouyang , Huan Huang , Yanting He , Jiajing Chen , Jiali Lin , Zhuling Chen , Zongwei Cai , Zian Lin . Utilization of hydralazine as a reactive matrix for enhanced detection and on-MALDI-target derivatization of saccharides. Chinese Chemical Letters, 2024, 35(5): 108885-. doi: 10.1016/j.cclet.2023.108885
2. [2]
  Xiaoyao Ma , Jinling Zhang , Ge Fang , He Gao , Jie Gao , Li Fu , Yuanyuan Hou , Gang Bai . Förster resonance energy transfer reveals phillygenin and swertiamarin concurrently target AKT on different binding domains to increase the anti-inflammatory effect. Chinese Chemical Letters, 2024, 35(5): 108823-. doi: 10.1016/j.cclet.2023.108823
3. [3]
  Han Han , Bi-Te Chen , Jia-Rong Ding , Jin-Ming Si , Tian-Jiao Zhou , Yi Wang , Lei Xing , Hu-Lin Jiang . A PDGFRβ-targeting nanodrill system for pancreatic fibrosis therapy. Chinese Chemical Letters, 2024, 35(10): 109583-. doi: 10.1016/j.cclet.2024.109583
4. [4]
  Jialiang XU , Jiabin CUI . Recent biological applications of corroles: From diagnosis to therapy. Chinese Journal of Inorganic Chemistry, 2024, 40(12): 2303-2317. doi: 10.11862/CJIC.20240245
5. [5]
  Ling Yang , Min Ren , Jie Wang , Liming He , Shanshan Wu , Shuai Yang , Wei Zhao , Hao Cheng , Xiaoming Zhou , Maling Gou . A non-viral gene therapy for melanoma by staphylococcal enterotoxin A. Chinese Chemical Letters, 2024, 35(5): 108822-. doi: 10.1016/j.cclet.2023.108822
6. [6]
  Huijie An , Chen Yang , Zhihui Jiang , Junjie Yuan , Zhongming Qiu , Longhao Chen , Xin Chen , Mutu Huang , Linlang Huang , Hongju Lin , Biao Cheng , Hongjiang Liu , Zhiqiang Yu . Luminescence-activated Pt(Ⅳ) prodrug for in situ triggerable cancer therapy. Chinese Chemical Letters, 2024, 35(7): 109134-. doi: 10.1016/j.cclet.2023.109134
7. [7]
  Mengjuan Sun , Muye Zhou , Yifang Xiao , Hailei Tang , Jinhua Chen , Ruitao Zhang , Chunjiayu Li , Qi Ya , Qian Chen , Jiasheng Tu , Qiyue Wang , Chunmeng Sun . Reversibly size-switchable polyion complex micelles for antiangiogenic cancer therapy. Chinese Chemical Letters, 2024, 35(7): 109110-. doi: 10.1016/j.cclet.2023.109110
8. [8]
  Tao LIU , Yuting TIAN , Ke GAO , Xuwei HAN , Ru'nan MIN , Wenjing ZHAO , Xueyi SUN , Caixia YIN . A photothermal agent with high photothermal conversion efficiency and high stability for tumor therapy. Chinese Journal of Inorganic Chemistry, 2024, 40(8): 1622-1632. doi: 10.11862/CJIC.20240107
9. [9]
  Bohan Chen , Liming Gong , Jing Feng , Mingji Jin , Liqing Chen , Zhonggao Gao , Wei Huang . Research advances of nanoparticles for CAR-T therapy in solid tumors. Chinese Chemical Letters, 2024, 35(9): 109432-. doi: 10.1016/j.cclet.2023.109432
10. [10]
  Jiangshan Xu , Weifei Zhang , Zhengwen Cai , Yong Li , Long Bai , Shaojingya Gao , Qiang Sun , Yunfeng Lin . Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy. Chinese Chemical Letters, 2024, 35(11): 109620-. doi: 10.1016/j.cclet.2024.109620
11. [11]
  Wei Su , Xiaoyan Luo , Peiyuan Li , Ying Zhang , Chenxiang Lin , Kang Wang , Jianzhuang Jiang . Phthalocyanine self-assembled nanoparticles for type Ⅰ photodynamic antibacterial therapy. Chinese Chemical Letters, 2024, 35(12): 109522-. doi: 10.1016/j.cclet.2024.109522
12. [12]
  Xiaofang Luo , Ye Wu , Xiaokun Zhang , Min Tang , Feiye Ju , Zuodong Qin , Gregory J Duns , Wei-Dong Zhang , Jiang-Jiang Qin , Xin Luan . Peptide-based strategies for overcoming multidrug-resistance in cancer therapy. Chinese Chemical Letters, 2025, 36(1): 109724-. doi: 10.1016/j.cclet.2024.109724
13. [13]
  Chao Zhang , Ai-Feng Liu , Shihui Li , Fang-Yuan Chen , Jun-Tao Zhang , Fang-Xing Zeng , Hui-Chuan Feng , Ping Wang , Wen-Chao Geng , Chuan-Rui Ma , Dong-Sheng Guo . A supramolecular formulation of icariin@sulfonatoazocalixarene for hypoxia-targeted osteoarthritis therapy. Chinese Chemical Letters, 2025, 36(1): 109752-. doi: 10.1016/j.cclet.2024.109752
14. [14]
  Jia-Qi Feng , Xiang Tian , Rui-Ge Cao , Yong-Xiu Li , Wen-Long Liu , Rong Huang , Si-Yong Qin , Ai-Qing Zhang , Yin-Jia Cheng . An AIE-based theranostic nanoplatform for enhanced colorectal cancer therapy: Real-time tumor-tracking and chemical-enhanced photodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109657-. doi: 10.1016/j.cclet.2024.109657
15. [15]
  Fengyun Li , Zerong Pei , Shuting Chen , Gen li , Mengyang Liu , Liqin Ding , Jingbo Liu , Feng Qiu . Multifunctional nano-herb based on tumor microenvironment for enhanced tumor therapy of gambogic acid. Chinese Chemical Letters, 2024, 35(5): 108752-. doi: 10.1016/j.cclet.2023.108752
16. [16]
  Yihao Zhang , Yang Jiao , Xianchao Jia , Qiaojia Guo , Chunying Duan . Highly effective self-assembled porphyrin MOCs nanomaterials for enhanced photodynamic therapy in tumor. Chinese Chemical Letters, 2024, 35(5): 108748-. doi: 10.1016/j.cclet.2023.108748
17. [17]
  Zhe Li , Ping-Zhao Liang , Li Xu , Fei-Yu Yang , Tian-Bing Ren , Lin Yuan , Xia Yin , Xiao-Bing Zhang . Three positive charge nonapoptotic-induced photosensitizer with excellent water solubility for tumor therapy. Chinese Chemical Letters, 2024, 35(8): 109190-. doi: 10.1016/j.cclet.2023.109190
18. [18]
  Huijiao Fu , Peiqin Liang , Qianwen Chen , Yan Wang , Guang Li , Xuzi Cai , Shengtao Wang , Kun Chen , Shengying Shi , Zhiqiang Yu , Xuefeng Wang . COX-2 blocking therapy in cisplatin chemosensitization of ovarian cancer: An allicin-based nanomedicine approach. Chinese Chemical Letters, 2024, 35(8): 109241-. doi: 10.1016/j.cclet.2023.109241
19. [19]
  Ningyue Xu , Jun Wang , Lei Liu , Changyang Gong . Injectable hydrogel-based drug delivery systems for enhancing the efficacy of radiation therapy: A review of recent advances. Chinese Chemical Letters, 2024, 35(8): 109225-. doi: 10.1016/j.cclet.2023.109225
20. [20]
  Qiang Li , Jiangbo Fan , Hongkai Mu , Lin Chen , Yongzhen Yang , Shiping Yu . Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108947-. doi: 10.1016/j.cclet.2023.108947

Get Citation

PDF

XML

Metrics

PDF Downloads(41)
Abstract views(1421)
HTML views(27)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142